Project 1: Dynamic Host Responses During Resolution of HAP Hospital-acquired pneumonia (HAP) is one of the leading causes of death from nosocomial infections, with high rates of associated mortality. HAP due to Pseudomonas aeruginosa and Acinetobacter spp. is substantially more difficult to treat than other pathogens, with clinical failure rates as high as 50%. These rates persist despite optimization of antibiotic regimens, suggesting factors beyond antibiotic resistance contribute. In this Project, we will examine the host response to pneumonia. We hypothesize that persistent inflammation in the alveolus after appropriate antibiotic treatment contributes to clinical failure in patients with P. aeruginosa or Acinetobacter spp. pneumonia. We will test this hypothesis in three interrelated Specific Aims.
Aim 1. To determine whether pathogen-associated changes in the transcriptomic signatures of alveolar macrophages and lymphocyte subsets over time predict outcome of severe pneumonia.
Aim 2. To prospectively validate predictive host responses identified using an ecosystem-based modeling approach in a separate cohort of patients with severe pneumonia.
Aim 3. To determine whether validated host responses predictive of clinical outcome are related to pneumonia endpoints in murine models. We will combine clinical data from the Electronic Health Record and integrate these clinical data with transcriptomic and epigenomic data obtained from flow sorted alveolar macrophages and Treg cells isolated from serial samples of NBBAL over the course of the patient's illness. Through the development of these predictive tools, the SCRIPT Systems Biology Center offers the potential to discover novel pathways that drive pneumonia pathobiology for therapeutic targeting, and the ability to revise understanding of pneumonia as a complex interaction between the host, pathogen, and microbiome.

Public Health Relevance

It is not required per instructions stated on the Funding Opportunity Announcement RFA-AI-16-080, Section IV. Application and Submission Information, Research Projects, Research & Related Other Project Information (Research Projects), ?Project Narrative: Do not complete?.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI135964-01
Application #
9454823
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-01-17
Budget End
2018-12-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Walter, James M; Wunderink, Richard G (2018) Testing for Respiratory Viruses in Adults With Severe Lower Respiratory Infection. Chest 154:1213-1222
Sala, Marc A; Balderas-Martínez, Yalbi Itzel; Buendía-Roldan, Ivette et al. (2018) Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis. Respir Res 19:233
Walter, James M; Helmin, Kathryn A; Abdala-Valencia, Hiam et al. (2018) Multidimensional assessment of alveolar T cells in critically ill patients. JCI Insight 3:
Ozer, Egon A (2018) ClustAGE: a tool for clustering and distribution analysis of bacterial accessory genomic elements. BMC Bioinformatics 19:150
Morales-Nebreda, Luisa; McLafferty, Fred S; Singer, Benjamin D (2018) DNA methylation as a transcriptional regulator of the immune system. Transl Res :
Katoh, Masaru (2018) Multi?layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/??catenin signaling activation (Review). Int J Mol Med 42:713-725
Rutherford, Victoria; Yom, Kelly; Ozer, Egon A et al. (2018) Environmental reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa. Environ Microbiol Rep 10:485-492
Ozer, Egon A; Hauser, Alan R; Gerding, Dale N et al. (2017) Complete Genome Sequence of Clostridioides difficile Epidemic Strain DH/NAP11/106/ST-42, Isolated from Stool from a Pediatric Patient with Diarrhea. Genome Announc 5: